title: Effects of cyclosporine pretreatment on tissue oxygen levels and cytochrome oxidase in skeletal muscle ischemia and reperfusion.
abstract: We hypothesized that pretreatment with single-dose cyclosporine (CsA) prevents alterations and improves tissue oxygen and mitochondrial cytochrome oxidase redox (CytOx) state in skeletal muscle ischemia and reperfusion-reoxygenation (I/R). Latissimus dorsi muscle was prepared and mobilized in New Zealand white rabbits. Ischemia was induced for 4 h, followed by 2 h of reperfusion. The animals were randomized to receive a 60-mg/kg intravenous bolus of CsA (CsA group, n = 10) or physiologic saline (control, n = 10) at 10 min before ischemia onset. Muscle tissue oxygen tension (PtO(2)) and mitochondrial CytOx were measured during I/R simultaneously. High-energy phosphate (HEP) levels were determined using high-field (31)P magnetic resonance spectroscopy. Mitochondrial viability index and wet-to-dry ratio were used to assess the tissue viability between groups. Decreases in tissue oxygen levels and CytOx were slower during ischemia in the CsA group in comparison to control group, also the loss of phosphocreatine and adenosine triphosphate depletion. After ischemia, recovery of tissue oxygen, mitochondrial CytOx, and HEP was delayed in controls. Tissue PtO2 in the CsA group (P < 0.05) was significantly higher compared with that in the control group after I/R. Mitochondrial CytOx was also improved in the CsA group (P < 0.01 vs. control). Muscle HEP levels (phosphocreatine, adenosine triphosphate) were significantly preserved in the CsA group versus the control group (P < 0.01, P < 0.05). Mitochondrial viability index and wet-to-dry ratio confirmed significantly preserved tissue and lower edema formation in the CsA group. The pretreatment with single-dose CsA prevents alterations and improves tissue oxygenation and mitochondrial oxidation in skeletal muscle I/R.
authors: Cardiovascular Program, Faculty of Health Sciences, Aarhus University and Aarhus University Hospital, Aarhus, Denmark.
authors: Dirk
authors: D
authors: Troitzsch
authors: Rainer
authors: R
authors: Moosdorf
authors: J Michael
authors: JM
authors: Hasenkam
authors: Hans
authors: H
authors: Nygaard
authors: Sebastian
authors: S
authors: Vogt
mesh_terms: D000255:Adenosine Triphosphate / Q000172:deficiency; D000818:Animals; D003250:Constriction; D016572:Cyclosporine / Q000494:pharmacology*; D004487:Edema / Q000517:prevention & control; D003576:Electron Transport Complex IV / Q000378:metabolism*; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D007511:Ischemia / Q000201:enzymology*; D008297:Male; D008931:Mitochondria, Muscle / Q000378:metabolism; D018482:Muscle, Skeletal / Q000098:blood supply* / Q000201:enzymology; D010100:Oxygen / Q000378:metabolism*; D010725:Phosphocreatine / Q000172:deficiency; D011817:Rabbits; D011897:Random Allocation; D015427:Reperfusion Injury / Q000517:prevention & control; D014022:Tissue Survival
chemical_list: D004791:Enzyme Inhibitors; D010725:Phosphocreatine; D016572:Cyclosporine; D000255:Adenosine Triphosphate; D003576:Electron Transport Complex IV; D010100:Oxygen